These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 208068)

  • 21. Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanine.
    Brady SF; Cochran DW; Nutt RF; Holly FW; Bennett CD; Paleveda WJ; Curley PE; Arison BH; Saperstein R; Veber DF
    Int J Pept Protein Res; 1984 Feb; 23(2):212-22. PubMed ID: 6142022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin, basic and clinical studies. A review.
    Schally AV; Meyers CA
    Mater Med Pol; 1980; 12(1-2):28-32. PubMed ID: 6120265
    [No Abstract]   [Full Text] [Related]  

  • 23. Structure-activity studies with somatostatin: the role of tryptophan in position 8.
    Hirst BH; Shaw B; Meyers CA; Coy DH
    Regul Pept; 1980 Oct; 1(2):97-113. PubMed ID: 6114515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemistry and pharmacology of SMS 201-995, a long-acting octapeptide analogue of somatostatin.
    Pless J; Bauer W; Briner U; Doepfner W; Marbach P; Maurer R; Petcher TJ; Reubi JC; Vonderscher J
    Scand J Gastroenterol Suppl; 1986; 119():54-64. PubMed ID: 2876507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity.
    Garsky VM; Clark DE; Grant NH
    Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A super active cyclic hexapeptide analog of somatostatin.
    Veber DF; Saperstein R; Nutt RF; Freidinger RM; Brady SF; Curley P; Perlow DS; Paleveda WJ; Colton CD; Zacchei AG
    Life Sci; 1984 Apr; 34(14):1371-8. PubMed ID: 6143233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel long-acting somatostatin analog with endocrine selectivity: potent suppression of growth hormone but not of insulin.
    Afargan M; Janson ET; Gelerman G; Rosenfeld R; Ziv O; Karpov O; Wolf A; Bracha M; Shohat D; Liapakis G; Gilon C; Hoffman A; Stephensky D; Oberg K
    Endocrinology; 2001 Jan; 142(1):477-86. PubMed ID: 11145612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin.
    Murphy WA; Lance VA; Moreau S; Moreau JP; Coy DH
    Life Sci; 1987 Jun; 40(26):2515-22. PubMed ID: 2885701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of gastric acid secretion by stereoisomers of somatostatin.
    Reed JD; Hirst BH; Gomez-Pan A; Coy DH; Schally AV; Meyers C
    Metabolism; 1978 Sep; 27(9 Suppl 1):1411-3. PubMed ID: 683010
    [No Abstract]   [Full Text] [Related]  

  • 30. [Phe4]somatostatin: a potent, selective inhibitor of growth hormone release.
    Meyers CA; Coy DH; Murphy WA; Redding TW; Arimura A; Schally AV
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):577-9. PubMed ID: 6987657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin and the gastrointestinal secretions.
    Konturek SJ
    Scand J Gastroenterol; 1976; 11(1):1-4. PubMed ID: 766152
    [No Abstract]   [Full Text] [Related]  

  • 32. Extrahypophyseal effects of somatostatin.
    Efendić S; Lins PE; Uvnäs-Wallensten K
    Ann Clin Res; 1978; 10(3):151-6. PubMed ID: 363038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
    Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
    J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatostatin analogs inhibit somatostatin release.
    Ipp E; Rivier J; Dobbs RE; Brown M; Vale W; Unger RH
    Endocrinology; 1979 May; 104(5):1270-3. PubMed ID: 436775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Somatostatin analogs which inhibit glucagon and growth hormone more than insulin release.
    Meyers C; Arimura A; Gordin A; Fernandez-Durango R; Coy DH; Schally AV; Drouin J; Ferland L; Beaulieu M; Labrie F
    Biochem Biophys Res Commun; 1977 Jan; 74(2):630-6. PubMed ID: 836315
    [No Abstract]   [Full Text] [Related]  

  • 36. Non-reducible cyclic, and azaphenylalanyl6 analogues of somatostatin.
    Hirst BH; Reed JD; Shaw B; Hayward CF; Morley JS
    Eur J Pharmacol; 1980 Jul; 65(2-3):151-6. PubMed ID: 6105084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on the mechanism of somatostatin action on insulin release. V. Effect of somatostatin analogues on arginine induced release of insulin and glucagon from the perfused rat pancreas.
    Efendić S; Lins PE; Luft R; Sievertsson H; Westin-Sjödal G
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):579-86. PubMed ID: 194446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and biological actions of prosomatostatin.
    Meyers CA; Murphy WA; Redding TW; Coy DH; Schally AV
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6171-4. PubMed ID: 6108563
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition by somatostatin (growth-hormone release-inhibiting hormone, GH-RIH) of gastric acid and pepsin and G-cell release of gastrin.
    Barros D'sa AA; Bloom SR; Baron JH
    Gut; 1978 Apr; 19(4):315-20. PubMed ID: 348581
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proghrelin-derived peptides influence the secretion of insulin, glucagon, pancreatic polypeptide and somatostatin: a study on isolated islets from mouse and rat pancreas.
    Qader SS; Håkanson R; Rehfeld JF; Lundquist I; Salehi A
    Regul Pept; 2008 Feb; 146(1-3):230-7. PubMed ID: 17942170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.